Detalhe da pesquisa
1.
Replication Fork Slowing and Reversal upon DNA Damage Require PCNA Polyubiquitination and ZRANB3 DNA Translocase Activity.
Mol Cell
; 67(5): 882-890.e5, 2017 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28886337
2.
Combination of lutetium-177 labelled anti-L1CAM antibody chCE7 with the clinically relevant protein kinase inhibitor MK1775: a novel combination against human ovarian carcinoma.
BMC Cancer
; 18(1): 922, 2018 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30253737
3.
Novel Therapeutic Strategies for Ovarian Cancer Stem Cells.
Front Oncol
; 10: 319, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32257947
4.
L1 Cell Adhesion Molecule Confers Radioresistance to Ovarian Cancer and Defines a New Cancer Stem Cell Population.
Cancers (Basel)
; 12(1)2020 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31952346